Prehab and rehab: simple diet and exercise program aims to boost recovery in elderly stomach cancer patients
NCT ID NCT07201857
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a 'peri-habilitation' program for 30 gastric cancer patients aged 65 and older. Participants receive nutrition education and protein-enriched soy milk for two weeks before surgery, plus exercise training and continued nutrition support for three weeks after leaving the hospital. The goal is to see if this approach prevents complications and speeds up recovery, measured by walking speed, balance, and strength tests.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- nutrition education with protein-enriched soy milk supplement and exercise training
- What this could lead to
- If it works, this could show that a simple program of nutrition and exercise helps older gastric cancer patients recover faster and have fewer complications after surgery.
- What could go wrong
- This is a very small early study with only 30 participants, so results may not apply to everyone. The program requires patients to be healthy enough to exercise, which may not be possible for all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 65 years or older who have been diagnosed with gastric cancer and are scheduled to undergo surgical treatment or chemotherapy. Exclusion Criteria: * Patients with severe conditions who are unable to undergo the intervention prior to surgical treatment or chemotherapy. * Patients with physical (e.g., musculoskeletal) or mental disorders that make participation in or continuation of the program impossible. * Patients judged to be at risk of additional physical burden from the intervention.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastric cancer (diagnosis) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Anam Hospital
Seoul, seongbuk-gu, 02841, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Direct-to-Abdomen chemotherapy tame GI cancers that spread?
- Can a nasal oxygen device prevent dangerous dips in blood oxygen during endoscopy for COPD patients?
- Targeted chemotherapy infusion aims to control advanced stomach cancer
- New cocktail aims to tackle stomach cancer relapse
- AI boosts Radiologists' accuracy in stomach cancer staging
- New app aims to ease recovery after cancer surgery